United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Turn Therapeutics Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -141.67% | -103.47% | - | 96.75% | 49.16% | 33.05% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -44.95% | -30.25% | -42.49% | -52.64% | -52.62% | -52.78% |
| Total Assets | $12,162.24K | $8,966.21K | $6,056.96K | $6,056.96K | $6,056.96K | $6,056.96K |
| Sector average | $3,280,499.23K | $3,298,345.31K | $3,676,894.01K | |||
| Net Income | -$3,194.08K | -$3,196.03K | -$3,191.75K | -$3,188.10K | -$3,187.04K | -$3,197.11K |
| $4,262,561.28K |
| $4,994,412.92K |
| $5,761,557.24K |